The federal contract award SPE2DB20D1004|SPE2DB25FNDCQ, valued at $4,345.60, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order with a firm fixed price, is for the supply of MYRBETRIQ ER 50 MG TABLET 30S and has an ultimate completion date of December 4, 2024.
The award was issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/4/25, 11:35 AM